NEURALSTEM INC CUR (AMEX) $ 1.61 Change: -0.09 -5.59% | Volume: 18,975
Sponsored by Click here!

NEURALSTEM INC - Fundamental Profile

Company Information

Ticker Symbol: CUR
Exchange: AMEX
Contact Info: 9700 Great Seneca Highway Rockville MD 20850 301-366-4841
CEO/President:
Industry: Medical - Biomedical / Standard Industry Code: 2836
Description: NEURALSTEM\'s patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.

Share Information

Shares Outstanding: 32,080 (000) Market Value: 54,650 ($000)
Percentage of Inst.Shareholders: 0.47% Number of Inst.Shareholders: 21.19%
Last Quarter Sales: 0.00 ($Mil.) Last Quarter Net Income: -2.96 ($Mil.)
Last Quarter EPS: -0.09 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -0.30
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN INC. +9.10 56.09
GILEAD SCIENCES -1.80 45.91
CELGENE CORPORA -8.00 58.56
BIOGEN IDEC INC -31.90 43.13
STEMCELLS INC. -56.40 1.23